Stada ‘Continuously Evaluating’ OTC Deals As Sales Grow Double Digits
Executive Summary
Stada tells HBW Insight it remains on the lookout for deals despite only last month closing the acquisition of a basket of OTC brands from GSK. The German firm revealed its plans as it reported a double-digit rise in both sales and earnings at its Branded Products business for the opening six months of 2019.